GeoPharma, Inc.

(NASDAQ:GORX)

View:
Quarterly Data
Annual Data
Note: All numbers in thousands

	Sep 30, 2008	Jun 30, 2008	Mar 31, 2008	Dec 31, 2007
Operating revenue
Total Revenue	16,040	20,025	23,890	18,237
Operating Revenue	16,040	20,025	23,890	18,237
Adjustments To Revenue	—	—	—	—
Cost Of Sales	12,982	15,985	19,010	14,395
Cost Of Sales With Depreciation	13,350	16,291	19,280	14,662
Gross Operating Profit	3,057	4,041	4,880	3,842
Operating Expenses
Research And Development Expenses	—	—	—	—
Selling General And Administrative Expenses	6,333	6,088	6,834	5,367
Advertising Expenses	—	—	—	—
Operating Income Before Depreciation	-3,276	-2,047	-1,954	-1,525
Operating Income	-4,369	-3,022	-2,783	-2,278
Depreciation	1,093	974	830	754
Depreciation Unreconciled	725	668	560	487
Amortization	—	—	—	—
Amortization Of Intangibles	—	—	—	—
Operating Income After Depreciation	-4,369	-3,022	-2,783	-2,278
Non Operating Expenses
Interest Expense	520	459	295	240
Pre Tax Income	-4,879	-3,476	-3,049	-2,508
Income Taxes	-956	-662	-94	-730
Minority Interest	-173	-198	-255	-202
Income Before Income Taxes	-4,879	-3,476	-3,049	-2,508
Net Income From Continuing Operations	-3,751	-2,616	-2,700	-1,576
Net Income From Discontinued Operations	—	—	—	—
Net Income From Total Operations	-3,751	-2,616	-2,700	-1,576
Non Recurring Events
Extraordinary Income Losses	—	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—	—
Income From Tax Loss Carryforward	—	—	—	—
Other Gains And Losses	—	—	—	—
Total Net Income	-3,751	-2,616	-2,700	-1,576
Normalized Income	-3,751	-2,616	-2,700	-1,576
NetIncome Available For Common	-3,889	-2,616	-2,800	-1,676
Preferred Dividends	138	—	100	100
Excise Taxes	—	—	—	—

	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006	Mar 31, 2005
Operating revenue
Total Revenue	54,968	59,792	49,744	28,230
Operating Revenue	54,968	59,792	49,744	28,230
Adjustments To Revenue	—	—	—	—
Cost Of Sales	43,083	41,342	36,673	22,414
Cost Of Sales With Depreciation	44,040	42,924	37,287	22,452
Gross Operating Profit	11,885	18,450	13,071	5,816
Operating Expenses
Research And Development Expenses	—	—	—	—
Selling General And Administrative Expenses	18,928	14,422	9,701	6,071
Advertising Expenses	—	—	—	—
Operating Income Before Depreciation	-7,043	4,028	3,369	-255
Operating Income	-9,867	1,282	2,007	-899
Depreciation	2,824	2,745	1,362	644
Depreciation Unreconciled	1,866	1,164	749	606
Amortization	—	—	—	—
Amortization Of Intangibles	—	—	—	—
Operating Income After Depreciation	-9,867	1,282	2,007	-899
Non Operating Expenses
Interest Expense	608	—	628	491
Pre Tax Income	-10,435	1,540	2,287	-1,084
Income Taxes	-2,510	343	1,081	-202
Minority Interest	-900	-1,310	-583	—
Income Before Income Taxes	-10,435	1,540	2,287	-184
Net Income From Continuing Operations	-7,025	2,507	1,789	-882
Net Income From Discontinued Operations	8	—	—	—
Net Income From Total Operations	-7,017	2,507	1,789	-882
Non Recurring Events
Extraordinary Income Losses	—	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—	—
Income From Tax Loss Carryforward	—	—	—	—
Other Gains And Losses	—	—	—	—
Total Net Income	-7,017	2,507	1,789	-882
Normalized Income	-7,025	2,507	1,789	-882
NetIncome Available For Common	-7,433	2,207	1,489	-1,403
Preferred Dividends	408	300	300	522
Excise Taxes	—	—	—	—